Technology | October 18, 2011

Randox Launches Acusera Troponin T Assay Quality Control

October 18, 2011 — Randox Laboratories announced the launch of a high sensitivity troponin T control. The new control allows clinical laboratories to more accurately monitor and assess the performance of their high sensitivity troponin T (hsTnT) assay.

Cardiac troponins are widely used in the detection of myocardial infarction (MI). Even small elevations in its levels indicate damage to the heart and possible MI. Both the European Society of Cardiology (ESC) and the American College of Cardiology (ACC) recommend using a highly sensitive troponin assay with excellent precision (less than 10 percent CV) at the 99th percentile of the reference range.

Before now, suitable control materials for hsTnT with target values sufficiently close to the 99th percentile of the reference range (14ng/L) were unavailable. The recent launch of the Randox Acusera High Sensitivity Troponin T Control now allows laboratories to more accurately monitor and assess the performance of their hsTnT assay.

The ultra low troponin T levels found in the Randox control are significantly lower than those found in other manufacturers’ quality control (QC) material. Target values are generally around 16.5ng/l (range 12.4 – 20.6ng/l) and are closest to the 14ng/ml cut off.

The Acusera control has a shelf life of up to four years, meaning the same lot of control material can be used for longer; this reduces the problems associated with lot crossovers. A reconstituted stability of five days at +2 - +8 degrees Celsius or four weeks at -20 degrees Celsius minimizes unnecessary waste and provides significant cost savings.

Randox also manufactures a liquid cardiac control with assayed values for 10 cardiac markers including BNP, CK-MB, D-dimer, Digoxin, Homocysteine, hsCRP, Myoglobin, NT-ProBNP, Troponin I and Troponin T. The control is liquid ready to use for added convenience and ease of use. Three levels are available spanning the complete clinical range with cut off levels for both Troponin I and T in line with international recommendations.

For more information:


Related Content

FDA Clears Abbott's High Sensitivity Troponin-I Blood Test
Technology | Blood Testing | October 09, 2019
Abbott recently announced that its Architect Stat High Sensitivity Troponin-I blood test has received clearance from...
Rapid Diagnosis Protocol for Chest Pain Does Not Improve Outcomes
News | Blood Testing | September 18, 2019
Discharge of patients with suspected acute coronary syndromes under a 0- and 1-hour high-sensitivity cardiac troponin T...
Validation Studies Confirm High Accuracy of Novel HART AI-Driven Blood Tests
News | Blood Testing | March 19, 2019
Prevencio Inc. announced data confirming the high accuracy of its artificial intelligence (AI)-driven, multiple-protein...
CoaguChek XS PT Test Strips Recalled for Inaccurately Reporting High INR
News | Blood Testing | December 28, 2018
Terrific Care LLC. / Medex Supply Dist Inc. initiated a nationwide recall on Dec. 19 of Roche CoaguChek test strips, as...
Abbott Point-of-Care Blood Test Speeds Heart Attack Diagnosis
News | Blood Testing | October 26, 2018
For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether...
New Noninvasive Blood Glucose Test as Effective as Finger Prick

Image courtesy of University of Missouri School of Medicine

News | Blood Testing | October 24, 2018
For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related...
Abbott Receives CE Mark for High Sensitive Troponin-I Test
News | Blood Testing | October 16, 2018
October 16, 2018 — Abbott announced that its High Sensitive Troponin-I...
AI-Driven Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patient
News | Blood Testing | September 04, 2018
Prevencio Inc. announced new data demonstrating its HART PAD test accurately diagnoses peripheral artery disease (PAD)...
More Sensitive Blood Test Diagnoses Heart Attacks Faster
News | Blood Testing | August 06, 2018
August 6, 2018 — A new test to assess a whether or not someone is having a...
Singulex cTnl Assay Can Identify Presence, Severity of CAD in Stable, Symptomatic Outpatients
News | Blood Testing | March 26, 2018
March 26, 2018 — Measurement of cardiac troponin in stable patients with chest pain using the ultra-sensitive Singule
Overlay Init